Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

This observational study aims to evaluate the implementation and use of the Tät®II app for the treatment of urgency and mixed urinary incontinence in women over the age of 18 after contact with ordinary healthcare, as well as its effectiveness. The study aims to answer the following question: Is treatment via the app effective and feasible after primary care? Participants will use the app for 15 weeks to treat urgency and mixed urinary incontinence. They will answer online survey questions about their urinary incontinence before, after 15 weeks, and one year after treatment.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Female gender

• Age ≥18 years

• Symptoms of urgency urinary incontinence or mixed urinary incontinence

• Medical evaluation and documentation of urinary incontinence by ordinary doctor

• Signed informed consent

Locations
Other Locations
Sweden
Region Jämtland Härjedalen
RECRUITING
Östersund
Contact Information
Primary
Annelie Olofsson, MD, PhD
annelie.olofsson@umu.se
+46 70 54 58 116
Backup
Emma Nyström, MD, PhD
emma.nystrom@umu.se
Time Frame
Start Date: 2025-06-12
Estimated Completion Date: 2027-06-01
Participants
Target number of participants: 60
Treatments
Women with symptoms of urgency urinary incontinence or mixed urinary incontinence.
Persons of the female gender, aged 18 years or older, with symptoms of urgency urinary incontinence or mixed urinary incontinence, who have undergone a medical evaluation and received a diagnosis of urinary incontinence from a primary care physician.
Related Therapeutic Areas
Sponsors
Collaborators: Region Jämtland Härjedalen
Leads: Umeå University

This content was sourced from clinicaltrials.gov